TD Cowen Maintains Buy on BeiGene, Raises Price Target to $236
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Werber has maintained a Buy rating on BeiGene (NASDAQ:BGNE) and increased the price target from $235 to $236.
April 24, 2024 | 5:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BeiGene's Buy rating is maintained by TD Cowen, with a slight increase in the price target from $235 to $236.
The maintenance of a Buy rating combined with a raised price target suggests a positive outlook on BeiGene's stock by TD Cowen. This could lead to increased investor confidence and potentially a short-term positive impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100